Toronto, Ontario–(Newsfile Corp. – August 30, 2021) – PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) (“ PharmaDrug” or the “Company“), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased to announce that David Kideckel will be…


Previous articleSmall Pharma Announces Appointment of Lyne Fortin as Chair of the Board
Next articlePT260 – Benjamin Mudge – Ayahuasca and Bipolar: Pathways to a Protocol